Clinical Trial Update: Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial completion reported for a study of Bavituximab in combination with Docetaxel in locally advanced or metastatic non-squamous non-small cell lung ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bavituximab (bavituximab)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Peregrine Pharmaceuticals | Conditions: Non-small-cell Lung Cancer | Phase 2 | Status: COMPLETED